Zimmer Biomet Holdings (ZBH) reported Q1 adjusted earnings Monday of $1.81 per diluted share, down from $1.94 a year earlier.

Analysts polled by FactSet expected $1.77.

Net sales for the quarter ended March 31 were $1.91 billion, up from $1.89 billion a year earlier.

Analysts surveyed by FactSet expected $1.9 billion.

The company said it now expects full-year adjusted EPS of $7.90 to $8.10, compared with its previous outlook range of $8.15 to $8.35.

Analysts polled by FactSet expect $8.19.

Zimmer said it now forecasts full-year revenue growth of 5.7% to 8.2%, up from its prior guidance of 1% to 3.5% increase.

The company's shares were up 1.5% in recent premarket activity.